Literature DB >> 30905725

Refractive Error Has Minimal Influence on the Risk of Age-Related Macular Degeneration: A Mendelian Randomization Study.

Ashley Wood1, Jeremy A Guggenheim2.   

Abstract

PURPOSE: To test the hypothesis that refractive errors such as myopia and hyperopia cause an increased risk of age-related macular degeneration (AMD) and to quantify the degree of risk.
DESIGN: Two-sample Mendelian randomization analysis of data from a genome-wide association study. PARTICIPANTS: As instrumental variables for refractive error, 126 genome-wide significant genetic variants identified by the Consortium for Refractive Error and Myopia and 23andMe Inc. were chosen. The association with refractive error for the 126 variants was obtained from a published study for a sample of 95,505 European ancestry participants from UK Biobank. Association with AMD for the 126 genetic variants was determined from a genome-wide association study (GWAS) published by the International Age-related Macular Degeneration Genomics consortium of 33,526 (16,144 cases and 17,832 controls) European ancestry participants.
METHODS: Two-sample Mendelian randomization (MR) analysis was used to assess the causal role of refractive error on AMD risk, using the 126 genetic variants associated with refractive error as instrumental variables, under the assumption that the relationship between refractive error and AMD risk is linear. MAIN OUTCOME MEASUREMENT: the risk AMD was caused by a 1-diopter (D) change in refractive error.
RESULTS: MR analysis suggested that refractive error had very limited influence on the risk of AMD. Specifically, 1 D more hyperopic refractive error was associated with an odds ratio (OR) of 1.080 (95% confidence interval [CI], 1.021-1.142; P = 0.007) increased risk of AMD. MR-Egger, MR pleiotropy residual sum and outlier, weighted median, and Phenoscanner-based sensitivity analyses detected minimal evidence to suggest that this result was biased by horizontal pleiotropy.
CONCLUSIONS: Under the assumption of a linear relationship between refractive error and the risk of AMD, myopia and hyperopia only minimally influence the causal risk for AMD. Thus, inconsistently reported strong associations between refractive error and AMD are likely to be the result of noncausal factors such as stochastic variation, confounding, or selection bias.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 30905725     DOI: 10.1016/j.ajo.2019.03.018

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Age- and sex-based evaluation of the association between refractive error and age-related macular degeneration in the Korean population.

Authors:  Kook Lee; Jin-Woo Kwon; Wan Jin Jahng; Young-Hoon Park; Donghyun Jee
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

2.  Causal effect of atrial fibrillation/flutter on chronic kidney disease: A bidirectional two-sample Mendelian randomization study.

Authors:  Masahiro Yoshikawa; Kensuke Asaba; Tomohiro Nakayama
Journal:  PLoS One       Date:  2021-12-13       Impact factor: 3.240

3.  Hyperopia Is Not Causally Associated With a Major Deficit in Educational Attainment.

Authors:  Denis Plotnikov; Nuala A Sheehan; Cathy Williams; Denize Atan; Jeremy A Guggenheim
Journal:  Transl Vis Sci Technol       Date:  2021-10-04       Impact factor: 3.283

4.  Body shape and risk of glaucoma: A Mendelian randomization.

Authors:  Ruolan Yuan; Kangcheng Liu; Yingjun Cai; Fei He; Xiaoxiong Xiao; Jing Zou
Journal:  Front Med (Lausanne)       Date:  2022-09-23

5.  Educational Attainment Decreases the Risk of COVID-19 Severity in the European Population: A Two-Sample Mendelian Randomization Study.

Authors:  Masahiro Yoshikawa; Kensuke Asaba
Journal:  Front Public Health       Date:  2021-06-03

6.  Plasma lipid levels and risk of primary open angle glaucoma: a genetic study using Mendelian randomization.

Authors:  Mengqiao Xu; Shengguo Li; Jundong Zhu; Dawei Luo; Weitao Song; Minwen Zhou
Journal:  BMC Ophthalmol       Date:  2020-10-02       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.